Smith & Nephew Discloses Increased Cevian Stake Above 13%
TipRanks' Prime Week Sale - 70% Off
- Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions.
- Discover top stock picks and new investment opportunities through TipRanks' Smart Investor Newsletter.
Smith & Nephew Snats ( (SNN) ) has provided an announcement.
Smith & Nephew disclosed that activist investor Cevian Capital II GP Limited has increased its stake in the company, according to a June 26, 2026 filing with U.S. regulators. The move underscores growing shareholder interest in the UK medical device maker, which has been under pressure to improve margins and accelerate growth.
Cevian crossed a UK disclosure threshold on June 23, 2026, lifting its voting interest from 12.24% to 13.06%, equivalent to about 110.5 million shares held via Aurora Nominees on behalf of UBS. The larger position strengthens Cevian’s influence over governance and strategic direction, potentially setting the stage for further engagement with Smith & Nephew’s board and management on performance and portfolio priorities.
The most recent analyst rating on (SNN) stock is a Hold
with a $30.00 price target.
To see the full list of analyst forecasts on Smith & Nephew Snats stock,
see the SNN Stock Forecast page.
Spark’s Take on SNN Stock
According to Spark, TipRanks’ AI Analyst, SNN is a Outperform.
The score is driven primarily by improving financial performance (margin and cash flow rebound) and supportive technicals (price above major moving averages with positive momentum). Valuation is only average at a 22.7 P/E, while the earnings call adds confidence via upbeat 2026 growth/profit guidance but flags meaningful near-term tariff and reimbursement headwinds.
To see Spark’s full report on SNN stock,
click here.
More about Smith & Nephew Snats
Smith & Nephew plc is a UK-based medical technology company listed in London and the U.S., known for orthopaedics, sports medicine, and advanced wound management products used in hospitals and clinics worldwide. The group focuses on surgical and wound care solutions for ageing populations and healthcare systems, competing with other global medtech players in reconstructive implants and minimally invasive procedures.
Average Trading Volume: 1,166,429
Technical Sentiment Signal: Hold
Current Market Cap: $12.79B
For a thorough assessment of SNN stock, go to TipRanks’ Stock Analysis page.
